BRIEF-SciClone Q2 non-GAAP earnings per share $0.30
August 09, 2017 at 16:25 PM EDT
* SciClone Pharmaceuticals Inc - in light of pending merger, company will not be updating its guidance for fiscal 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.